Pope Francis Raises Vatican Immigration Czar to Rank of

New Post Public Reply Private Reply Replies (1) Message Board
PoemStone cashclan #38454
236
Pope Francis Raises Vatican Immigration Czar to Rank of Cardinal
< >

Pope-Francis-migrants-getty-640x480.jpg

Pope Francis has announced his intention to elevate the head of the Vatican’s immigration department to the rank of cardinal.

In his weekly Angelus address in Saint Peter’s Square on Sunday, the pope said he will be creating 13 new cardinals in a special consistory this coming October and among them will be Jesuit Father Michael Czerny, who runs the Migrant and Refugee Department of the Vatican’s office for Promoting Integral Human Development.

As veteran Vatican journalist John L. Allen notes, Father Czerny “has been the pope’s right-hand man on migrant and refugee issues” and is recognized by Vatican-watchers as a reward to a man who has understood the pope’s priorities and has made them his own.

Contrary to usual practice, the pope is naming Czerny to the college of cardinals despite the fact that Czerny is not a bishop, but merely a priest. Pope Francis — the first Jesuit pope — has also not been shy about elevating members of his own Jesuit order to positions of prominence and influence in the Church.

Along with climate change and environmental issues, Pope Francis has made the immigration question a central plank in his pontifical platform.

In 2018, the pope published an extensive letter in which he insisted that immigration and the care of migrants should be considered a central issue for Catholics, since Jesus commanded his followers to welcome the stranger.

“We often hear it said that, with respect to relativism and the flaws of our present world, the situation of migrants, for example, is a lesser issue,” Francis wrote. “Some Catholics consider it a secondary issue compared to the ‘grave’ bioethical questions.”

“That a politician looking for votes might say such a thing is understandable, but not a Christian, for whom the only proper attitude is to stand in the shoes of those brothers and sisters of ours who risk their lives to offer a future to their children,” he said.

“Can we not realize that this is exactly what Jesus demands of us, when he tells us that in welcoming the stranger we welcome him?” he asked.

The pontiff defended his continual insistence on the issue of migration by saying it was not just his pet cause but a key teaching of the bible.

“This is not a notion invented by some Pope, or a momentary fad. In today’s world too, we are called to follow the path of spiritual wisdom proposed by the prophet Isaiah to show what is pleasing to God,” he said.

While the pope did not state how this principle is to be translated into political policy, he has made it clear he thinks governments should be more open to welcoming migrants.

For his part, Father Czerny has been a vigorous executor of the pope’s vision of immigration.

Last year, for instance, Czerny accused the Pope’s critics of being “obsessed” with national security and border control, which leads them to be overly fearful of migrants.

Asked in an interview with Italian media whether the Pope isn’t “obsessed” with the immigration question, Father Czerny replied that it isn’t Pope Francis who is obsessive, but rather his critics.

Many would say that the modern “obsession with borders and national security to the detriment of the rights and dignity of refugees and refugees” is excessive, the priest declared. And for many others, “the media predilection for sensational stories that feed xenophobia and isolationism is also excessive,” he added.

For many people, “the way in which politicians create or exaggerate a sense of crisis to obtain short-term advantages is decidedly excessive,” he said.

Citing the Secretary General of the United Nations, António Guterres, Czerny said that “the rise of nationalism and xenophobia must be counted among the new dangers for global peace and stability.”

“Far from criticizing the Pope’s attention,” he said, “many good people—and I think they are the overwhelming majority—are indeed deeply grateful for his moral guidance and good example.”

“And I agree with him when he says: ‘Those who fuel fear towards migrants, perhaps for political ends, instead of building peace, sow violence, racial discrimination and xenophobia,’” he said.

The college of cardinals, which will soon include Michael Czerny, are those entrusted with electing the future pope when they gather in conclave.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 84

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 21

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Morgan Stanley Projects Strong Upswing for Consumer Finance

Updated Category News Views 259

Morgan Stanley's Positive Outlook for Consumer Finance Stocks Morgan Stanley has recently made an uplifting adjustment to its outlook on consumer finance stocks, now branding them as "attractive." This decision stems from robust fundamentals and an improved regulatory environment, setting an optimistic tone for the sector. Key Drivers of Change The primary catalysts...

Continue Reading
Significant Board Restructuring at O2Gold Inc. Announced

Updated Category News Views 71

O2Gold Board Announces Key Changes O2Gold Inc. (NEX: OTGO.H), a dedicated mineral exploration company, has recently undergone a significant change in its board structure. The company has announced that Roger Lemaitre has resigned from his position as a director. This decision marks a pivotal moment for O2Gold as it continues to navigate its exploration initiatives....

Continue Reading
Taylor Morrison Launches Holiday Initiative to Support Homeowners

Updated Category News Views 265

Help for Homeowners During the Holidays In a time when financial strain can be prominent, especially during the holidays, Taylor Morrison (NYSE: TMHC) is stepping up to lend a hand. The renowned homebuilder has introduced an initiative designed to support homeowners facing the threat of foreclosure. With the holiday season often heightening financial challenges, the...

Continue Reading
flatexDEGIRO Moves Ahead After Ending BaFin Oversight

Updated Category News Views 188

flatexDEGIRO Ends Special Commissioner Mandate FRANKFURT - flatexDEGIRO AG, a prominent German financial services provider, has officially announced the conclusion of the special commissioner mandate set by the Federal Financial Supervisory Authority (BaFin). This change will take effect on a specified date in the future. The company has made significant strides in...

Continue Reading
Investigating Alvotech's Regulatory Challenges After Stock Drop

Updated Category News Views 125

Alvotech Faces Scrutiny over Manufacturing Issues National shareholder rights firm Hagens Berman is currently analyzing Alvotech (NASDAQ: ALVO) regarding potential misrepresentations in their disclosures tied to manufacturing operations and the regulatory status of their primary biosimilar candidate, AVT05. Impact of FDA's Complete Response Letter The investigation stems...

Continue Reading